Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Fossati

Showing results (1-10 of 247) with videos related to

Pageof 25
Sort By:
The Journal of Urology|April 8, 2015
Re: Editorial Comment on Clinical Performance of Serum Isoform (-2)proPSA (p2PSA) and its Derivatives, Namely %p2PSA and PHI (Prostate Health Index) in Men Younger than 60 Years of Age: Results from a Multicentric European Study: S. S. Taneja J Urol 2014;192:421Nicola Fossati, Massimo Lazzeri, Alessandro Larcher
Current Opinion in Urology|August 9, 2017
Salvage surgery for nodal recurrent prostate cancerMarco Bandini, Nicola Fossati, Alberto Briganti
Current Opinion in Urology|August 11, 2018
Nomograms in urologic oncology, advantages and disadvantagesMarco Bandini, Nicola Fossati, Alberto Briganti
European Urology|February 4, 2018
Reply to Mustafa Z. Temiz and Huseyin Besiroglu's Letter to the Editor re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7Giorgio Gandaglia, Nicola Fossati, Francesco Montorsi, et al.
European Urology|January 26, 2020
Re: Felix Preisser, Felix K.H. Chun, Raisa S. Pompe, et al. Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes. Eur Urol 2019;76:106-14Francesco Montorsi, Nicola Fossati, Giorgio Gandaglia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2015
Does Radiotherapy Plus Androgen-Deprivation Therapy Represent the Best Treatment Approach in Elderly Patients With Locally Advanced Prostate Cancer?Giorgio Gandaglia, Nicola Fossati, Francesco Montorsi, et al.
The Journal of Urology|May 5, 2020
Re: Comparison of Initial Experience with Transrectal Magnetic Resonance Imaging Cognitive Guided Micro-Ultrasound Biopsies versus Established Transperineal Robotic Ultrasound Magnetic Resonance Imaging Fusion Biopsies for Prostate CancerO. R. Claros, R. R. Tourinho-Barbosa, A. Fregeville, A. C. Gallardo, F. Muttin, A. Carneiro, A. Stabile, M. Moschini, P. Macek, N. Cathala, A. Mombet, R. Sanchez-Salas and X. Cathelineau <i>J Urol</i> 2020; <b>203:</b> 918-925Giorgio Gandaglia, Alberto Briganti, Nicola Fossati, et al.
The Journal of Urology|April 14, 2020
Prospective Validation of Gallium-68 Prostate Specific Membrane Antigen-Positron Emission Tomography/Computerized Tomography for Primary Staging of Prostate Cancer. LetterFrancesco Montorsi, Nicola Fossati, Giorgio Gandaglia, et al.
The Journal of Urology|July 2, 2020
Re: The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate BiopsiesA. Amin, M. J. Scheltema, R. Shnier, A. Blazevski, D. Moses, T. Cusick, A. Siriwardena, B. Yuen, P. J. van Leeuwen, A. M. Haynes, J. Matthews, P. Brenner, G. O'Neill, C. Yuen, W. Delprado, P. Stricker and J. Thompson <i>J Urol</i> 2020; <b>203:</b> 910-917Francesco Montorsi, Giorgio Gandaglia, Nicola Fossati, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2016
The Authors RespondNicola Fossati, Alessandro Larcher, Alberto Briganti, et al.
Pageof 25

Showing results (1-10 of 247) with videos related to

Sort By:
Pageof 25
The Journal of Urology|April 8, 2015
Re: Editorial Comment on Clinical Performance of Serum Isoform (-2)proPSA (p2PSA) and its Derivatives, Namely %p2PSA and PHI (Prostate Health Index) in Men Younger than 60 Years of Age: Results from a Multicentric European Study: S. S. Taneja J Urol 2014;192:421Nicola Fossati, Massimo Lazzeri, Alessandro Larcher
Current Opinion in Urology|August 9, 2017
Salvage surgery for nodal recurrent prostate cancerMarco Bandini, Nicola Fossati, Alberto Briganti
Current Opinion in Urology|August 11, 2018
Nomograms in urologic oncology, advantages and disadvantagesMarco Bandini, Nicola Fossati, Alberto Briganti
European Urology|February 4, 2018
Reply to Mustafa Z. Temiz and Huseyin Besiroglu's Letter to the Editor re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7Giorgio Gandaglia, Nicola Fossati, Francesco Montorsi, et al.
European Urology|January 26, 2020
Re: Felix Preisser, Felix K.H. Chun, Raisa S. Pompe, et al. Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes. Eur Urol 2019;76:106-14Francesco Montorsi, Nicola Fossati, Giorgio Gandaglia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2015
Does Radiotherapy Plus Androgen-Deprivation Therapy Represent the Best Treatment Approach in Elderly Patients With Locally Advanced Prostate Cancer?Giorgio Gandaglia, Nicola Fossati, Francesco Montorsi, et al.
The Journal of Urology|May 5, 2020
Re: Comparison of Initial Experience with Transrectal Magnetic Resonance Imaging Cognitive Guided Micro-Ultrasound Biopsies versus Established Transperineal Robotic Ultrasound Magnetic Resonance Imaging Fusion Biopsies for Prostate CancerO. R. Claros, R. R. Tourinho-Barbosa, A. Fregeville, A. C. Gallardo, F. Muttin, A. Carneiro, A. Stabile, M. Moschini, P. Macek, N. Cathala, A. Mombet, R. Sanchez-Salas and X. Cathelineau <i>J Urol</i> 2020; <b>203:</b> 918-925Giorgio Gandaglia, Alberto Briganti, Nicola Fossati, et al.
The Journal of Urology|April 14, 2020
Prospective Validation of Gallium-68 Prostate Specific Membrane Antigen-Positron Emission Tomography/Computerized Tomography for Primary Staging of Prostate Cancer. LetterFrancesco Montorsi, Nicola Fossati, Giorgio Gandaglia, et al.
The Journal of Urology|July 2, 2020
Re: The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate BiopsiesA. Amin, M. J. Scheltema, R. Shnier, A. Blazevski, D. Moses, T. Cusick, A. Siriwardena, B. Yuen, P. J. van Leeuwen, A. M. Haynes, J. Matthews, P. Brenner, G. O'Neill, C. Yuen, W. Delprado, P. Stricker and J. Thompson <i>J Urol</i> 2020; <b>203:</b> 910-917Francesco Montorsi, Giorgio Gandaglia, Nicola Fossati, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2016
The Authors RespondNicola Fossati, Alessandro Larcher, Alberto Briganti, et al.
Pageof 25